Bottom line
PHSYX vs FHLC: the short answer
PHSYX (Putnam Global Health Care Fund) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 67% by weight.
But FHLC is far broader, holding 337 positions to 115 for PHSYX, so beyond the top names it adds exposure PHSYX doesn't have.
FHLC is cheaper at 0.084% vs 0.79% — a difference of $71 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +7.2% for FHLC (reporting dates differ).
Updated Nov 19, 2026
PHSYX vs FHLC side by side
| PHSYX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.79% | 0.084% |
| Annual cost per $10k | $79 | $8.4 |
| 10-yr cost on $10k (prospectus) | $978 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +1.5% | +2.6% |
| 5-yr return (annualized) | +8.1% | +7.2% |
| 10-yr return (annualized) | +7.8% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $1.5B | $3.3B |
| Number of holdings | 115 | 337 |
| Portfolio turnover | 67% | 3% |
| Returns as of | Dec 31, 2024 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of PHSYX's top 25 holdings also appear in FHLC's top 25.
| Holding | PHSYX | FHLC |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.35% |
| Johnson & Johnson | 8.46% | 8.93% |
| UnitedHealth Group, Inc. | 6.93% | 5.44% |
| AbbVie, Inc. | 6.05% | 6.42% |
| Merck & Co., Inc. | 4.88% | 4.66% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.09% |
| Intuitive Surgical, Inc. | 4.04% | 1.82% |
| CVS Health Corp. | 2.74% | 1.92% |
| Gilead Sciences, Inc. | 2.63% | 2.34% |
| McKesson Corp. | 2.14% | 1.52% |
| Cardinal Health, Inc. | 2.12% | 0.78% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.76% |
| Boston Scientific Corp. | 1.80% | 1.00% |
| Bristol-Myers Squibb Co. | 1.75% | 1.93% |
| HCA Healthcare, Inc. | 1.18% | 0.91% |
Source: SEC Form N-PORT
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between PHSYX and FHLC?
Which is cheaper, PHSYX or FHLC?
Should I own both PHSYX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.